IM CANNABIS CORP
IMCCNASDAQTrading Snapshot
- Day Range
- $2.52 – $2.57
- 52-Week Range
- $1.55 – $77.10
- Volume
- $1.88B
- Avg Volume
- $1.49B
- Shares Outstanding
- 603,920
- Next Earnings
- Dec 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $55M
- Last Q Revenue
- $8M
- P/E Ratio
- -1062.5
- P/S Ratio
- 0.7x
- EPS (TTM)
- $-0.04
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +91.1%
Why Investors Own IMCC
- ✓High-growth profile — revenue up +1.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 72% gross margin and 19% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
IM CANNABIS CORP
IMCC
StockOtter · stockotter.spaceAbout IM CANNABIS CORP
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ: IMCC), t
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on Septembe
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has
IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market
The Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hybrid Fixed-Wing VTOL-
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a U